2023-2029 Global Antiemetics for Cancer Treatment Industry Research & Trends Analysis Report
2023-2029 Global Antiemetics for Cancer Treatment Industry Research & Trends Analysis Report
The Antiemetics for Cancer Treatment study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Latest Study, the global market for Antiemetics for Cancer Treatment should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Antiemetics for Cancer Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Antiemetics for Cancer Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Serotonin Receptor Antagonists segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Highly Emetogenic Chemotherapy has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Antiemetics for Cancer Treatment include Heron Therapeutics, Inc, Sandoz International GmbH, Merck & Co., Inc, Eisai Co., Ltd, Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche Ltd, Mylan N.V, GSK plc and Mundipharma International, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Emetogenic symptoms are associated with nausea and vomiting associated with cancer treatments such as chemotherapy, radiation therapy, and drug therapy. Nausea and vomiting are major side effects of cancer treatment. It is important that nausea and vomiting are controlled so patients can continue treatment and have a better quality of life. Nausea and vomiting, primarily due to, can also be induced in patients receiving chemotherapy and radiation therapy of the brain, gastrointestinal tract, or liver.
This report aims to provide a comprehensive study of the global market for Antiemetics for Cancer Treatment. Report Highlights:
(1) Global Antiemetics for Cancer Treatment market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Antiemetics for Cancer Treatment market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Antiemetics for Cancer Treatment market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Antiemetics for Cancer Treatment segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Antiemetics for Cancer Treatment segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Antiemetics for Cancer Treatment, capacity, production and trends.
(7) Antiemetics for Cancer Treatment industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Serotonin Receptor Antagonists
Neurokinin-1 Receptor Antagonist
Corticosteroids
Olanzapine
Other
Market segment by application, can be divided into
Highly Emetogenic Chemotherapy
Moderately Emetogenic Chemotherapy
Low Emetogenic Chemotherapy
Market segment by players, this report covers
Heron Therapeutics, Inc
Sandoz International GmbH
Merck & Co., Inc
Eisai Co., Ltd
Teva Pharmaceutical Industries Ltd
F. Hoffmann-La Roche Ltd
Mylan N.V
GSK plc
Mundipharma International
Baxter
Bayer AG
Cipla Inc
Sanofi
Sun Pharmaceutical Industries Ltd
Qilu Pharmaceutical Co.,Ltd
1 Market Overview
1.1 Antiemetics for Cancer Treatment Definition
1.2 Global Antiemetics for Cancer Treatment Market Size and Forecast
1.2.1 By Revenue, Global Antiemetics for Cancer Treatment Market Size, 2018-2029
1.2.2 By Sales Volume, Global Antiemetics for Cancer Treatment Market Size, 2018-2029
1.2.3 Global Antiemetics for Cancer Treatment Price Trend, 2018-2029
1.3 China Antiemetics for Cancer Treatment Market Size and Forecast
1.3.1 By Revenue, China Antiemetics for Cancer Treatment Market Size, 2018-2029
1.3.2 By Sales Volume, China Antiemetics for Cancer Treatment Market Size, 2018-2029
1.3.3 China Antiemetics for Cancer Treatment Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Antiemetics for Cancer Treatment Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Antiemetics for Cancer Treatment Share in Global Market, 2018-2029
1.4.3 Antiemetics for Cancer Treatment Market Size: China VS Global, 2018-2029
1.5 Antiemetics for Cancer Treatment Market Dynamics
1.5.1 Antiemetics for Cancer Treatment Market Drivers
1.5.2 Antiemetics for Cancer Treatment Market Restraints
1.5.3 Antiemetics for Cancer Treatment Industry Trends
1.5.4 Antiemetics for Cancer Treatment Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Antiemetics for Cancer Treatment Revenue by Company, 2018-2023
2.2 Global Antiemetics for Cancer Treatment Sales Volume by Company, 2018-2023
2.3 Global Antiemetics for Cancer Treatment Price by Company, 2018-2023
2.4 Global Antiemetics for Cancer Treatment Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Antiemetics for Cancer Treatment Concentration Ratio
2.6 Global Antiemetics for Cancer Treatment Mergers & Acquisitions, Expansion Plans
2.7 Global Antiemetics for Cancer Treatment Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Antiemetics for Cancer Treatment Revenue by Company, 2018-2023
3.2 China Antiemetics for Cancer Treatment Sales Volume by Company, 2018-2023
3.3 China Antiemetics for Cancer Treatment Antiemetics for Cancer Treatment Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Antiemetics for Cancer Treatment Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Antiemetics for Cancer Treatment Domestic VS Export
3.6 China Market, Antiemetics for Cancer Treatment Import & Export
3.6.1 China Market, Antiemetics for Cancer Treatment Import & Export, 2018-2029
3.6.2 China Antiemetics for Cancer Treatment Import & Export Trends
3.6.3 Main Sources of China Antiemetics for Cancer Treatment Import
3.6.4 Export Destination of China Antiemetics for Cancer Treatment
4 Antiemetics for Cancer Treatment Production by Region
4.1 Global Antiemetics for Cancer Treatment Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Antiemetics for Cancer Treatment Manufacturers
4.3 Global Major Manufacturers, Antiemetics for Cancer Treatment Capacity Expansion and Future Plans
4.4 Global Antiemetics for Cancer Treatment Capacity by Region
4.5 Global Antiemetics for Cancer Treatment Production by Region
4.5.1 Global Antiemetics for Cancer Treatment Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Antiemetics for Cancer Treatment Production by Region, 2018-2023
4.5.3 Global Antiemetics for Cancer Treatment Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Antiemetics for Cancer Treatment Industry Chain
5.2 Antiemetics for Cancer Treatment Upstream Analysis
5.2.1 Antiemetics for Cancer Treatment Core Raw Materials
5.2.2 Main Manufacturers of Antiemetics for Cancer Treatment Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Antiemetics for Cancer Treatment Production Mode
5.6 Antiemetics for Cancer Treatment Procurement Model
5.7 Antiemetics for Cancer Treatment Industry Sales Model and Sales Channels
5.7.1 Antiemetics for Cancer Treatment Sales Model
5.7.2 Antiemetics for Cancer Treatment Typical Distributors
6 Sights by Type
6.1 Antiemetics for Cancer Treatment Classification
6.1.1 Serotonin Receptor Antagonists
6.1.2 Neurokinin-1 Receptor Antagonist
6.1.3 Corticosteroids
6.1.4 Olanzapine
6.1.5 Other
6.2 By Type, Global Antiemetics for Cancer Treatment Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Antiemetics for Cancer Treatment Revenue, 2018-2029
6.4 By Type, Global Antiemetics for Cancer Treatment Sales Volume, 2018-2029
6.5 By Type, Global Antiemetics for Cancer Treatment Price, 2018-2029
7 Sights by Application
7.1 Antiemetics for Cancer Treatment Segment by Application
7.1.1 Highly Emetogenic Chemotherapy
7.1.2 Moderately Emetogenic Chemotherapy
7.1.3 Low Emetogenic Chemotherapy
7.2 By Application, Global Antiemetics for Cancer Treatment Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Antiemetics for Cancer Treatment Revenue, 2018-2029
7.4 By Application, Global Antiemetics for Cancer Treatment Sales Volume, 2018-2029
7.5 By Application, Global Antiemetics for Cancer Treatment Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Antiemetics for Cancer Treatment Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Antiemetics for Cancer Treatment Revenue, 2018-2029
8.3 By Region, Global Antiemetics for Cancer Treatment Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Antiemetics for Cancer Treatment Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Antiemetics for Cancer Treatment Market Size Market Share
8.5 Europe
8.5.1 Europe Antiemetics for Cancer Treatment Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Antiemetics for Cancer Treatment Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Antiemetics for Cancer Treatment Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Antiemetics for Cancer Treatment Market Size Market Share
8.7 South America
8.7.1 South America Antiemetics for Cancer Treatment Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Antiemetics for Cancer Treatment Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Antiemetics for Cancer Treatment Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Antiemetics for Cancer Treatment Revenue, 2018-2029
9.3 By Country, Global Antiemetics for Cancer Treatment Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Antiemetics for Cancer Treatment Market Size, 2018-2029
9.4.2 By Company, U.S. Antiemetics for Cancer Treatment Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Antiemetics for Cancer Treatment Market Size, 2018-2029
9.5.2 By Company, Europe Antiemetics for Cancer Treatment Sales Volume Market Share, 2022
9.5.3 By Type, Europe Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Antiemetics for Cancer Treatment Market Size, 2018-2029
9.6.2 By Company, China Antiemetics for Cancer Treatment Sales Volume Market Share, 2022
9.6.3 By Type, China Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Antiemetics for Cancer Treatment Market Size, 2018-2029
9.7.2 By Company, Japan Antiemetics for Cancer Treatment Sales Volume Market Share, 2022
9.7.3 By Type, Japan Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Antiemetics for Cancer Treatment Market Size, 2018-2029
9.8.2 By Company, South Korea Antiemetics for Cancer Treatment Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Antiemetics for Cancer Treatment Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Antiemetics for Cancer Treatment Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Antiemetics for Cancer Treatment Market Size, 2018-2029
9.10.2 By Company, India Antiemetics for Cancer Treatment Sales Volume Market Share, 2022
9.10.3 By Type, India Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Antiemetics for Cancer Treatment Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Antiemetics for Cancer Treatment Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Heron Therapeutics, Inc
10.1.1 Heron Therapeutics, Inc Company Information, Head Office, Market Area and Industry Position
10.1.2 Heron Therapeutics, Inc Antiemetics for Cancer Treatment Models, Specifications and Application
10.1.3 Heron Therapeutics, Inc Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Heron Therapeutics, Inc Company Profile and Main Business
10.1.5 Heron Therapeutics, Inc Recent Developments
10.2 Sandoz International GmbH
10.2.1 Sandoz International GmbH Company Information, Head Office, Market Area and Industry Position
10.2.2 Sandoz International GmbH Antiemetics for Cancer Treatment Models, Specifications and Application
10.2.3 Sandoz International GmbH Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Sandoz International GmbH Company Profile and Main Business
10.2.5 Sandoz International GmbH Recent Developments
10.3 Merck & Co., Inc
10.3.1 Merck & Co., Inc Company Information, Head Office, Market Area and Industry Position
10.3.2 Merck & Co., Inc Antiemetics for Cancer Treatment Models, Specifications and Application
10.3.3 Merck & Co., Inc Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Merck & Co., Inc Company Profile and Main Business
10.3.5 Merck & Co., Inc Recent Developments
10.4 Eisai Co., Ltd
10.4.1 Eisai Co., Ltd Company Information, Head Office, Market Area and Industry Position
10.4.2 Eisai Co., Ltd Antiemetics for Cancer Treatment Models, Specifications and Application
10.4.3 Eisai Co., Ltd Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Eisai Co., Ltd Company Profile and Main Business
10.4.5 Eisai Co., Ltd Recent Developments
10.5 Teva Pharmaceutical Industries Ltd
10.5.1 Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
10.5.2 Teva Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Models, Specifications and Application
10.5.3 Teva Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Teva Pharmaceutical Industries Ltd Company Profile and Main Business
10.5.5 Teva Pharmaceutical Industries Ltd Recent Developments
10.6 F. Hoffmann-La Roche Ltd
10.6.1 F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position
10.6.2 F. Hoffmann-La Roche Ltd Antiemetics for Cancer Treatment Models, Specifications and Application
10.6.3 F. Hoffmann-La Roche Ltd Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 F. Hoffmann-La Roche Ltd Company Profile and Main Business
10.6.5 F. Hoffmann-La Roche Ltd Recent Developments
10.7 Mylan N.V
10.7.1 Mylan N.V Company Information, Head Office, Market Area and Industry Position
10.7.2 Mylan N.V Antiemetics for Cancer Treatment Models, Specifications and Application
10.7.3 Mylan N.V Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Mylan N.V Company Profile and Main Business
10.7.5 Mylan N.V Recent Developments
10.8 GSK plc
10.8.1 GSK plc Company Information, Head Office, Market Area and Industry Position
10.8.2 GSK plc Antiemetics for Cancer Treatment Models, Specifications and Application
10.8.3 GSK plc Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 GSK plc Company Profile and Main Business
10.8.5 GSK plc Recent Developments
10.9 Mundipharma International
10.9.1 Mundipharma International Company Information, Head Office, Market Area and Industry Position
10.9.2 Mundipharma International Antiemetics for Cancer Treatment Models, Specifications and Application
10.9.3 Mundipharma International Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Mundipharma International Company Profile and Main Business
10.9.5 Mundipharma International Recent Developments
10.10 Baxter
10.10.1 Baxter Company Information, Head Office, Market Area and Industry Position
10.10.2 Baxter Antiemetics for Cancer Treatment Models, Specifications and Application
10.10.3 Baxter Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Baxter Company Profile and Main Business
10.10.5 Baxter Recent Developments
10.11 Bayer AG
10.11.1 Bayer AG Company Information, Head Office, Market Area and Industry Position
10.11.2 Bayer AG Antiemetics for Cancer Treatment Models, Specifications and Application
10.11.3 Bayer AG Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Bayer AG Company Profile and Main Business
10.11.5 Bayer AG Recent Developments
10.12 Cipla Inc
10.12.1 Cipla Inc Company Information, Head Office, Market Area and Industry Position
10.12.2 Cipla Inc Antiemetics for Cancer Treatment Models, Specifications and Application
10.12.3 Cipla Inc Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Cipla Inc Company Profile and Main Business
10.12.5 Cipla Inc Recent Developments
10.13 Sanofi
10.13.1 Sanofi Company Information, Head Office, Market Area and Industry Position
10.13.2 Sanofi Antiemetics for Cancer Treatment Models, Specifications and Application
10.13.3 Sanofi Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Sanofi Company Profile and Main Business
10.13.5 Sanofi Recent Developments
10.14 Sun Pharmaceutical Industries Ltd
10.14.1 Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
10.14.2 Sun Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Models, Specifications and Application
10.14.3 Sun Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Sun Pharmaceutical Industries Ltd Company Profile and Main Business
10.14.5 Sun Pharmaceutical Industries Ltd Recent Developments
10.15 Qilu Pharmaceutical Co.,Ltd
10.15.1 Qilu Pharmaceutical Co.,Ltd Company Information, Head Office, Market Area and Industry Position
10.15.2 Qilu Pharmaceutical Co.,Ltd Antiemetics for Cancer Treatment Models, Specifications and Application
10.15.3 Qilu Pharmaceutical Co.,Ltd Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Qilu Pharmaceutical Co.,Ltd Company Profile and Main Business
10.15.5 Qilu Pharmaceutical Co.,Ltd Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Antiemetics for Cancer Treatment Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Antiemetics for Cancer Treatment Market Restraints
Table 3. Antiemetics for Cancer Treatment Market Trends
Table 4. Antiemetics for Cancer Treatment Industry Policy
Table 5. Global Antiemetics for Cancer Treatment Revenue by Company, 2018-2023, US$ million
Table 6. Global Antiemetics for Cancer Treatment Revenue Market Share by Company, 2018-2023
Table 7. Global Antiemetics for Cancer Treatment Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Antiemetics for Cancer Treatment Sales Volume Market Share by Company, 2018-2023
Table 9. Global Antiemetics for Cancer Treatment Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Antiemetics for Cancer Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Antiemetics for Cancer Treatment Mergers & Acquisitions, Expansion Plans
Table 12. Global Antiemetics for Cancer Treatment Manufacturers Product Type
Table 13. China Antiemetics for Cancer Treatment Revenue by Company, 2018-2023, US$ million
Table 14. China Antiemetics for Cancer Treatment Revenue Market Share by Company, 2018-2023
Table 15. China Antiemetics for Cancer Treatment Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Antiemetics for Cancer Treatment Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Antiemetics for Cancer Treatment Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Antiemetics for Cancer Treatment Import & Export Trends
Table 19. Main Sources of China Antiemetics for Cancer Treatment Import
Table 20. Export Destination of China Antiemetics for Cancer Treatment
Table 21. Global Headquarters and Manufacturing Base of Antiemetics for Cancer Treatment Manufacturers
Table 22. Global Major Manufacturers, Antiemetics for Cancer Treatment Capacity Expansion and Future Plans
Table 23. Global Antiemetics for Cancer Treatment Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Antiemetics for Cancer Treatment Production by Region, 2018-2023, (K Units)
Table 25. Global Antiemetics for Cancer Treatment Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Antiemetics for Cancer Treatment Upstream (Raw Materials)
Table 27. Global Antiemetics for Cancer Treatment Typical Customers
Table 28. Antiemetics for Cancer Treatment Typical Distributors
Table 29. By Type, Global Antiemetics for Cancer Treatment Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Antiemetics for Cancer Treatment Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Antiemetics for Cancer Treatment Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Antiemetics for Cancer Treatment Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Antiemetics for Cancer Treatment Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Antiemetics for Cancer Treatment Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Antiemetics for Cancer Treatment Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Antiemetics for Cancer Treatment Revenue Market Share, 2018-2029
Table 37. By Country, Global Antiemetics for Cancer Treatment Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Antiemetics for Cancer Treatment Sales Volume Market Share, 2018-2029
Table 39. Heron Therapeutics, Inc Company Information, Head Office, Market Area and Industry Position
Table 40. Heron Therapeutics, Inc Antiemetics for Cancer Treatment Models, Specifications and Application
Table 41. Heron Therapeutics, Inc Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Heron Therapeutics, Inc Company Profile and Main Business
Table 43. Heron Therapeutics, Inc Recent Developments
Table 44. Sandoz International GmbH Company Information, Head Office, Market Area and Industry Position
Table 45. Sandoz International GmbH Antiemetics for Cancer Treatment Models, Specifications and Application
Table 46. Sandoz International GmbH Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Sandoz International GmbH Company Profile and Main Business
Table 48. Sandoz International GmbH Recent Developments
Table 49. Merck & Co., Inc Company Information, Head Office, Market Area and Industry Position
Table 50. Merck & Co., Inc Antiemetics for Cancer Treatment Models, Specifications and Application
Table 51. Merck & Co., Inc Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Merck & Co., Inc Company Profile and Main Business
Table 53. Merck & Co., Inc Recent Developments
Table 54. Eisai Co., Ltd Company Information, Head Office, Market Area and Industry Position
Table 55. Eisai Co., Ltd Antiemetics for Cancer Treatment Models, Specifications and Application
Table 56. Eisai Co., Ltd Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Eisai Co., Ltd Company Profile and Main Business
Table 58. Eisai Co., Ltd Recent Developments
Table 59. Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
Table 60. Teva Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Models, Specifications and Application
Table 61. Teva Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Teva Pharmaceutical Industries Ltd Company Profile and Main Business
Table 63. Teva Pharmaceutical Industries Ltd Recent Developments
Table 64. F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position
Table 65. F. Hoffmann-La Roche Ltd Antiemetics for Cancer Treatment Models, Specifications and Application
Table 66. F. Hoffmann-La Roche Ltd Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. F. Hoffmann-La Roche Ltd Company Profile and Main Business
Table 68. F. Hoffmann-La Roche Ltd Recent Developments
Table 69. Mylan N.V Company Information, Head Office, Market Area and Industry Position
Table 70. Mylan N.V Antiemetics for Cancer Treatment Models, Specifications and Application
Table 71. Mylan N.V Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Mylan N.V Company Profile and Main Business
Table 73. Mylan N.V Recent Developments
Table 74. GSK plc Company Information, Head Office, Market Area and Industry Position
Table 75. GSK plc Antiemetics for Cancer Treatment Models, Specifications and Application
Table 76. GSK plc Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. GSK plc Company Profile and Main Business
Table 78. GSK plc Recent Developments
Table 79. Mundipharma International Company Information, Head Office, Market Area and Industry Position
Table 80. Mundipharma International Antiemetics for Cancer Treatment Models, Specifications and Application
Table 81. Mundipharma International Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Mundipharma International Company Profile and Main Business
Table 83. Mundipharma International Recent Developments
Table 84. Baxter Company Information, Head Office, Market Area and Industry Position
Table 85. Baxter Antiemetics for Cancer Treatment Models, Specifications and Application
Table 86. Baxter Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Baxter Company Profile and Main Business
Table 88. Baxter Recent Developments
Table 89. Bayer AG Company Information, Head Office, Market Area and Industry Position
Table 90. Bayer AG Antiemetics for Cancer Treatment Models, Specifications and Application
Table 91. Bayer AG Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Bayer AG Company Profile and Main Business
Table 93. Bayer AG Recent Developments
Table 94. Cipla Inc Company Information, Head Office, Market Area and Industry Position
Table 95. Cipla Inc Antiemetics for Cancer Treatment Models, Specifications and Application
Table 96. Cipla Inc Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Cipla Inc Company Profile and Main Business
Table 98. Cipla Inc Recent Developments
Table 99. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 100. Sanofi Antiemetics for Cancer Treatment Models, Specifications and Application
Table 101. Sanofi Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Sanofi Company Profile and Main Business
Table 103. Sanofi Recent Developments
Table 104. Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position
Table 105. Sun Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Models, Specifications and Application
Table 106. Sun Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Sun Pharmaceutical Industries Ltd Company Profile and Main Business
Table 108. Sun Pharmaceutical Industries Ltd Recent Developments
Table 109. Qilu Pharmaceutical Co.,Ltd Company Information, Head Office, Market Area and Industry Position
Table 110. Qilu Pharmaceutical Co.,Ltd Antiemetics for Cancer Treatment Models, Specifications and Application
Table 111. Qilu Pharmaceutical Co.,Ltd Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Qilu Pharmaceutical Co.,Ltd Company Profile and Main Business
Table 113. Qilu Pharmaceutical Co.,Ltd Recent Developments
List of Figure
Figure 1. Antiemetics for Cancer Treatment Picture
Figure 2. By Revenue, Global Antiemetics for Cancer Treatment Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Antiemetics for Cancer Treatment Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Antiemetics for Cancer Treatment Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Antiemetics for Cancer Treatment Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Antiemetics for Cancer Treatment Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Antiemetics for Cancer Treatment Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Antiemetics for Cancer Treatment Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Antiemetics for Cancer Treatment Share of Global Market, 2018-2029
Figure 10. Global Antiemetics for Cancer Treatment Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Antiemetics for Cancer Treatment Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Antiemetics for Cancer Treatment Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Antiemetics for Cancer Treatment Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Antiemetics for Cancer Treatment Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Antiemetics for Cancer Treatment Domestic VS Export, 2022
Figure 16. Global Antiemetics for Cancer Treatment Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Antiemetics for Cancer Treatment Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Antiemetics for Cancer Treatment Production Market Share & Forecast by Region, 2018-2029
Figure 19. Antiemetics for Cancer Treatment Industry Chain
Figure 20. Antiemetics for Cancer Treatment Procurement Model
Figure 21. Antiemetics for Cancer Treatment Sales Model
Figure 22. Antiemetics for Cancer Treatment Sales Channels, Direct Sales and Distribution
Figure 23. Serotonin Receptor Antagonists
Figure 24. Neurokinin-1 Receptor Antagonist
Figure 25. Corticosteroids
Figure 26. Olanzapine
Figure 27. Other
Figure 28. By Type, Global Antiemetics for Cancer Treatment Revenue, 2018-2029, US$ Million
Figure 29. By Type, Global Antiemetics for Cancer Treatment Revenue Market Share, 2018-2029
Figure 30. By Type, Global Antiemetics for Cancer Treatment Sales Volume, 2018-2029, (K Units)
Figure 31. By Type, Global Antiemetics for Cancer Treatment Sales Volume Market Share, 2018-2029
Figure 32. By Type, Global Antiemetics for Cancer Treatment Price, 2018-2029, (US$/Unit)
Figure 33. Highly Emetogenic Chemotherapy
Figure 34. Moderately Emetogenic Chemotherapy
Figure 35. Low Emetogenic Chemotherapy
Figure 36. By Application, Global Antiemetics for Cancer Treatment Revenue, 2018-2029, US$ Million
Figure 37. By Application, Global Antiemetics for Cancer Treatment Revenue Market Share, 2018-2029
Figure 38. By Application, Global Antiemetics for Cancer Treatment Sales Volume, 2018-2029, (K Units)
Figure 39. By Application, Global Antiemetics for Cancer Treatment Sales Volume Market Share, 2018-2029
Figure 40. By Application, Global Antiemetics for Cancer Treatment Price, 2018-2029, (US$/Unit)
Figure 41. By Region, Global Antiemetics for Cancer Treatment Revenue Market Share, 2018-2029
Figure 42. By Region, Global Antiemetics for Cancer Treatment Sales Volume Market Share, 2018-2029
Figure 43. North America Antiemetics for Cancer Treatment Revenue & Foreca
Research Methodology:
Antiemetics for Cancer Treatment Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|